Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Sept 2021 for Nabriva Therapeutics plc, €33. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert Crotty: trading record in brief
Robert Crotty is a declared insider of Nabriva Therapeutics plc, with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 30 April 2021 to 31 August 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 2 September 2021, the filings show a share grant worth €33 in Nabriva Therapeutics plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Crotty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
37 shares@ US$1.066.3% of flowOrdinary SharesSEC:0001104659-21-112476:0
74 shares@ US$1.1713.8% of flowOrdinary SharesSEC:0001104659-21-102949:0
37 shares@ US$1.106.5% of flowOrdinary SharesSEC:0001104659-21-099443:0
74 shares@ US$1.2715.0% of flowOrdinary SharesSEC:0001104659-21-090212:0
37 shares@ US$1.357.9% of flowOrdinary SharesSEC:0001104659-21-088844:0
73 shares@ US$1.3415.2% of flowOrdinary SharesSEC:0001104659-21-078216:0
37 shares@ US$1.387.9% of flowOrdinary SharesSEC:0001104659-21-075734:0
74 shares@ US$1.4917.2% of flowOrdinary SharesSEC:0001104659-21-064052:0
37 shares@ US$1.7810.2% of flowOrdinary SharesSEC:0001104659-21-060954:0
9 of 9 declarations
